Antioxidant Supplements: An Evidence-Based Approach to Health Benefits and Risks

  • Goran Bjelakovic
  • Dimitrinka Nikolova
  • Christian Gluud


The major issues of the modern medicine in high-income countries are how to prevent chronic diseases including cancer and cardiovascular diseases in order to prolong life span. It has been speculated that the aging process and development of chronic diseases are consequences of oxidative damage to cells and tissues. Oxidative stress defined as an imbalance between oxidants and antioxidants in our body in favour of the former (Sies 1985) is thought to cause a spectrum of diseases. During human life, an antioxidant network counteracts the deleterious action of reactive oxygen species. Our cells synthesize some antioxidants, while other are obtained from diet. The beneficial influence of diet on health has been known since Ancient Greeks (Jones 1923). It has been suggested that specific diet like high intake of fruits and vegetables is associated with a lower cancer incidence and lower risk of death. The protective effect of dietary fruits and vegetables has been ascribed to the antioxidant vitamins and trace elements. The question whether antioxidant supplements may protect against chronic diseases and cancer and prolong life span has drawn much attention. Some researchers have even hypothesized that long-living animal species have more efficient antioxidant systems than shorter-living species (Cutler 1991).


Gastrointestinal Cancer Colorectal Adenoma Biliary Tract Cancer Antioxidant Vitamin Antioxidant Supplement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. Bast A, Haenen GR (2002) The toxicity of antioxidants and their metabolites. Environ Toxicol Pharmacol 11:251–258PubMedCrossRefGoogle Scholar
  2. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C (2004a) Antioxidant supplements for preventing gastrointestinal cancers. Cochrane Database Syst Rev, Issue 4, Art. No.: CD004183.pub2. doi: 10.1002/14651858.CD004183.pub2Google Scholar
  3. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C (2004b) Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta–analysis. Lancet 364:1219–1228PubMedCrossRefGoogle Scholar
  4. Bjelakovic G, Nagorni A, Nikolova D, Simonetti RG, Bjelakovic M, Gluud C (2006) Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment Pharmacol Ther 24:281–291PubMedCrossRefGoogle Scholar
  5. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta–analysis. JAMA 297:842–857PubMedCrossRefGoogle Scholar
  6. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2008) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev (2):CD007176Google Scholar
  7. Bleys J, Navas-Acien A, Guallar E (2007) Serum selenium and diabetes in U.S. adults. Diabetes Care 30:829–834PubMedCrossRefGoogle Scholar
  8. Camire ME, Kantor MA (1999) Dietary supplements: nutritional and legal considerations. Food Technol 53:87–95Google Scholar
  9. Clark LC, Cantor KP, Allaway WH (1991) Selenium in forage crops and cancer mortality in U.S. counties. Arch Environ Health 46:37–42PubMedCrossRefGoogle Scholar
  10. Cutler RG (1991) Antioxidants and aging. Am J Clin Nutr 53:373S–379SPubMedGoogle Scholar
  11. Ferlay J, Bray F, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence. Mortality and prevalence worldwide. IARC cancer base no. 5, version 2.0. IARC Press, LyonGoogle Scholar
  12. Hanck AB (1988) Vitamin C and cancer. Prog Clin Biol Res 259:307–320PubMedGoogle Scholar
  13. Herbert V, Subak-Sharpe GJ, Hammock D (eds) (1990) The Mount Sinai School of Medicine complete book of nutrition. St Martin’s Press, New YorkGoogle Scholar
  14. Higgins JPT, Green S (eds) (2008) Cochrane handbook for systematic reviews of interventions version 5.0.0 [updated Feb 2008]. The Cochrane Collaboration. Available from
  15. Hughes D (2000) Dietary antioxidants and human immune function. Nutr Bull 25:35–41CrossRefGoogle Scholar
  16. Jones WHS (ed) (1923) Hippocrates. Nutriment 351Google Scholar
  17. Knekt P (1994) Vitamin E and cancer prevention. In: Frei B (ed) Natural antioxidants in human health and disease. Academic Press, San Diego, pp 199–239Google Scholar
  18. Lippman SM, Klein EA, Goodman PJ et al (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin E effect of selenium and vitamin E on risk of prostate cancer prevention trial (SELECT). JAMA 301(1):39–51PubMedCrossRefGoogle Scholar
  19. Millen AE, Dodd KW, Subar AF (2004) Use of vitamin, mineral, nonvitamin, and nonmineral supplements in the United States: the 1987, 1992, and 2000 National Health Interview Survey results. J Am Diet Assoc 104:942–950PubMedCrossRefGoogle Scholar
  20. Mulholland CA, Benford DJ (2007) What is known about the safety of multivitamin-multimineral supplements for the generally healthy population? Theoretical basis for harm. Am J Clin Nutr 85:318S–322SPubMedGoogle Scholar
  21. Oshima H, Berezial J (1982) Monitoring N-nitrosamino acids excreted in the urine and feces of rats as an index of endogenous nitrozation. Carcinogenesis 3:115–120CrossRefGoogle Scholar
  22. Panel on Dietary Antioxidants and Related Compounds, Subcommittees on Upper Reference Levels of Nutrients, Interpretation and Uses of DRIs, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine (2000) Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. National Academy Press, Washington, DC, pp 1–529Google Scholar
  23. Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients, Interpretation and Use of Dietary Reference Intakes, Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Institute of Medicine, Food and Nutrition Board (2000) Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. National Academy Press, Washington, DC, pp 1–800Google Scholar
  24. Paolini M, Abdel-Rahman SZ, Sapone A, Pedulli GF, Perocco P, Cantelli-Forti G et al (2003) Beta-carotene: a cancer chemopreventive agent or a co-carcinogen? Mutat Res 7719:1–6Google Scholar
  25. Peto R, Doll R, Buckley JD, Sporn MB (1981) A dietary carotene materially reduces human cancer rates? Nature 290:201–208PubMedCrossRefGoogle Scholar
  26. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J (1998) Vitamin C exhibits pro-oxidant properties. Nature 392:559PubMedCrossRefGoogle Scholar
  27. Poppel G, Berg H (1997) Vitamins and cancer. Cancer Lett 114:195–202PubMedCrossRefGoogle Scholar
  28. Rayman M (2000) The importance of selenium to human health. Lancet 356:233–241PubMedCrossRefGoogle Scholar
  29. Salganik RI (2001) The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 20:464S–472SPubMedGoogle Scholar
  30. Schrauzer GN, White DA, Schneider CJ (1977) Cancer mortality correlation studies. III. Statistical association with dietary selenium intakes. Bioinorg Chem 7:35–56PubMedCrossRefGoogle Scholar
  31. Sies H (1985) Introductory remarks. In: Sies H (ed) Oxidative stress. Academic, Orlando, pp 1–7Google Scholar
  32. Sporn MB, Dunlop NM, Newton DL, Smith JM (1976) Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 35:1332–1338PubMedGoogle Scholar
  33. Stranges S, Marshall JR, Natarajan R, Donahue RP, Trevisan M, Combs GF et al (2007) Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 147:217–223PubMedGoogle Scholar
  34. Vertuani S, Angusti A, Manfredini S (2004) The antioxidants and pro-antioxidants network: an overview. Curr Pharm Des 10:1677–1694PubMedCrossRefGoogle Scholar
  35. Woo JJ (2007) Adverse event monitoring and multivitamin-multimineral dietary supplements. Am J Clin Nutr 85:323S–324SPubMedGoogle Scholar
  36. Ziegler RG (1989) A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J Nutr 119:116–122PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2012

Authors and Affiliations

  • Goran Bjelakovic
    • 1
    • 2
  • Dimitrinka Nikolova
    • 1
    • 2
  • Christian Gluud
    • 1
    • 2
  1. 1.Department of Internal Medicine – Gastroenterology and Hepatology, Medical FacultyUniversity of NisNisSerbia
  2. 2.The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, RigshospitaletCopenhagen University HospitalCopenhagenDenmark

Personalised recommendations